key: cord-0845804-n63x9yu2
authors: Dillinger, Jean Guillaume; Benmessaoud, Fatima Azzahra; Pezel, Théo; Voicu, Sebastian; Sideris, Georgios; Chergui, Naima; Hamzi, Lounis; Chauvin, Anthony; Leroy, Pierre; Gautier, Jean François; Sène, Damien; Henry, Patrick
title: Coronary Artery Calcification and Complications in Patients With COVID-19
date: 2020-11-02
journal: JACC Cardiovasc Imaging
DOI: 10.1016/j.jcmg.2020.07.004
sha: 0b509d54f7b576f095a7302e884e26d68c71df5c
doc_id: 845804
cord_uid: n63x9yu2

nan

portably to facilitate sanitation, and the examination was performed by a single operator, reducing patient contact with the device. RV end-diastolic diameters and mPAP values were significantly increased in patients with cardiac injury, whereas the tricuspid inflow E/A ratio (the ratio of peak velocity blood flow from LV relaxation in early diastole [E wave] to peak velocity flow in late diastole caused by atrial contraction [A wave]) and TAPSE were reduced ( Table 1) . All patients were treated with oxygen, and the percentages of use of noninvasive ventilation and invasive mechanical ventilation were 16.5 % (19 patients) and 9. 5 Values are mean AE SD or n (%).

COVID-19 ¼ coronavirus disease-2019; E/A ¼ ratio of peak velocity blood flow from LV relaxation in early diastole [E wave] to peak velocity flow in late diastole caused by atrial contraction [A wave]); LV ¼ left ventricle; MPAP ¼ mean pulmonary artery pressure; NS ¼ not significant; PASP ¼ pulmonary artery systolic pressure; RV ¼ right ventricle; TAPSE ¼ tricuspid annular systolic plane excursion; TRV ¼ tricuspid regurgitation velocity. Our study shows that the presence and extent of CAC are associated with a worse prognosis in is associated with a mortality rate of more than 20%, and even 50% when surgery is indicated and not performed (2, 3) .

We compared the number of cases of IE diagnosed in 2 regional tertiary reference centers from Belgium 

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality

Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis

Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients

Clinical characteristics of coronavirus disease 2019 in China

Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study

Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review

Coronary artery calcium scoring

A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19

The authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Cardiovascular Imaging author instructions page.The authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Cardiovascular Imaging author instructions page.